ロード中...
Evaluation of the Expression Profile of Irinotecan-Induced Diarrhea in Patients with Colorectal Cancer
Irinotecan (CPT-11) is widely used for the treatment of unresectable colorectal cancer in combination with fluoropyrimidines, such as 5-fluorouracil and S-1. Diarrhea is one of the adverse effects associated with CPT-11 and frequently reported by patients treated with CPT-11-containing regimens comb...
保存先:
| 出版年: | Pharmaceuticals (Basel) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8073045/ https://ncbi.nlm.nih.gov/pubmed/33921605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14040377 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|